Morgan Stanley’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.12M | Buy |
1,437,407
+985,716
| +218% | +$4.2M | ﹤0.01% | 3885 |
|
|
2025
Q1 | $1.7M | Sell |
451,691
-572,786
| -56% | -$2.15M | ﹤0.01% | 4708 |
|
|
2024
Q4 | $5.97M | Buy |
1,024,477
+774,876
| +310% | +$4.52M | ﹤0.01% | 3855 |
|
|
2024
Q3 | $2.98M | Sell |
249,601
-85,970
| -26% | -$1.03M | ﹤0.01% | 4371 |
|
|
2024
Q2 | $3.63M | Sell |
335,571
-162,555
| -33% | -$1.76M | ﹤0.01% | 4141 |
|
|
2024
Q1 | $5.64M | Sell |
498,126
-497,562
| -50% | -$5.63M | ﹤0.01% | 3823 |
|
|
2023
Q4 | $14M | Buy |
995,688
+944,162
| +1,832% | +$13.2M | ﹤0.01% | 3649 |
|
|
2023
Q3 | $636K | Sell |
51,526
-11,331
| -18% | -$140K | ﹤0.01% | 5055 |
|
|
2023
Q2 | $568K | Sell |
62,857
-51,033
| -45% | -$461K | ﹤0.01% | 5141 |
|
|
2023
Q1 | $395K | Sell |
113,890
-89,032
| -44% | -$309K | ﹤0.01% | 5391 |
|
|
2022
Q4 | $497K | Sell |
202,922
-84,582
| -29% | -$207K | ﹤0.01% | 5257 |
|
|
2022
Q3 | $793K | Sell |
287,504
-148,928
| -34% | -$411K | ﹤0.01% | 5017 |
|
|
2022
Q2 | $1.78M | Sell |
436,432
-168,828
| -28% | -$687K | ﹤0.01% | 4626 |
|
|
2022
Q1 | $2.58M | Buy |
605,260
+12,935
| +2% | +$55.1K | ﹤0.01% | 4330 |
|
|
2021
Q4 | $5.54M | Buy |
592,325
+506,201
| +588% | +$4.74M | ﹤0.01% | 3611 |
|
|
2021
Q3 | $2.37M | Sell |
86,124
-39,036
| -31% | -$1.08M | ﹤0.01% | 4429 |
|
|
2021
Q2 | $3.5M | Buy |
125,160
+63,702
| +104% | +$1.78M | ﹤0.01% | 4147 |
|
|
2021
Q1 | $2.04M | Buy |
61,458
+15,690
| +34% | +$521K | ﹤0.01% | 4244 |
|
|
2020
Q4 | $2.2M | Buy |
+45,768
| New | +$2.2M | ﹤0.01% | 4067 |
|